RxSight, Inc. to Present at the J.P. Morgan Healthcare Conference

RxSight (NASDAQ:RXST) announced that its management will present at the J.P.

Rhea-AI Summary

RxSight (NASDAQ:RXST) announced that its management will present at the J.P. Morgan Healthcare Conference on Tuesday, January 13, 2026 at 3:45 p.m. PT / 6:45 p.m. ET.

Investors and interested parties can access a live and archived webcast of the presentation at https://investors.rxsight.com/. No financial results or guidance were included in the announcement.

Argus Jan 5 session

+0.77% close to close Open Argus

Details

News Market Reaction – RXST

On Jan 5, the first trading day after this news, RXST closed 0.77% above the previous close.

Data tracked by StockTitan Argus for the Jan 5 session.

Key Figures

Conference date: January 13, 2026 Presentation time PT: 3:45 p.m. PT Presentation time ET: 6:45 p.m. ET

Conference date

January 13, 2026

Scheduled J.P. Morgan Healthcare Conference presentation

Presentation time PT

3:45 p.m. PT

Scheduled presentation time at conference

Presentation time ET

6:45 p.m. ET

Corresponding Eastern Time for presentation

Historical Context

5 past events · Latest: Dec 22

5 events

1. Dec 22

   CFO transition

   24h Move

   +1.7%

   CFO transition with consulting support and stable outlook message.

2. Nov 20

   Conference appearance

   24h Move

   -5.8%

   Piper Sandler healthcare conference presentation announcement.

3. Nov 05

   Q3 2025 earnings

   24h Move

   -7.3%

   Lower Q3 revenue, wider loss, but strong margins and updated guidance.

4. Oct 22

   Earnings date notice

   24h Move

   -1.2%

   Announcement of Q3 results release date and investor call details.

5. Oct 16

   Medical meeting events

   24h Move

   -2.8%

   Live learning sessions showcasing Light Adjustable Lens at AAO 2025.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Key Terms

ophthalmic, cataract surgery, webcast

3 terms

ophthalmic medical

"RxSight, Inc., an ophthalmic medical device company dedicated to providing..."

Relating to the eye and its care, including medicines, drops, diagnostic tools and surgical devices used to prevent, diagnose or treat eye conditions. Investors care because ophthalmic products form a distinct market with specialized safety approvals, manufacturing needs and payer coverage, so success or failure in this area can drive steady revenue or costly setbacks—think of it as a niche, high‑safety consumer product line for vision health.

cataract surgery medical

"customized vision to patients following cataract surgery, today announced plans..."

A surgical procedure that removes a cloudy natural lens in the eye and usually replaces it with a clear artificial lens, restoring vision much like cleaning or replacing a fogged camera lens to get a sharp picture again. It matters to investors because the procedure drives demand for medical devices, implants, surgical equipment and related services, so changes in procedure volume, technology, pricing or reimbursement can directly affect revenue and growth prospects for healthcare companies.

webcast technical

"Interested parties may access a live and archived webcast of the presentation..."

A webcast is a live or recorded online event where people watch or listen to presentations, announcements, or performances through the internet. It’s like a TV broadcast but over the internet, allowing viewers from anywhere to tune in in real time or later. Webcasts are important because they let companies share information quickly and widely with audiences around the world.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

ALISO VIEJO, Calif., Jan. 02, 2026 (GLOBE NEWSWIRE) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced plans to participate in the upcoming J.P. Morgan Healthcare Conference.

RxSight’s management is scheduled to present on Tuesday, January 13, 2026, at 3:45 p.m. Pacific Time / 6:45 p.m. Eastern Time. Interested parties may access a live and archived webcast of the presentation at: https://investors.rxsight.com/.

About RxSight, Inc.

RxSight, Inc. is an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery. The RxSight® Light Adjustable Lens system, comprised of the RxSight Light Adjustable Lens® (LAL®/LAL+®, collectively the “LAL”), RxSight Light Delivery Device (LDD™) and accessories, is the first and only commercially available intraocular lens (IOL) technology that can be adjusted after surgery, enabling doctors to customize and deliver high-quality vision to patients after cataract surgery. Additional information about RxSight can be found at www.rxsight.com.

Company Contact:
Shelley B. Thunen
Chief Financial Officer
sthunen@rxsight.com

Investor Relations Contact:
Oliver Moravcevic
VP, Investor Relations
omoravcevic@rxsight.com

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will RxSight (RXST) present at the J.P. Morgan Healthcare Conference?

RxSight management will present on January 13, 2026 at 3:45 p.m. PT / 6:45 p.m. ET.

How can investors watch the RxSight (RXST) presentation at the JP Morgan conference?

Investors can access a live and archived webcast at https://investors.rxsight.com/.

What topics will RxSight (RXST) cover in its January 13, 2026 presentation?

The announcement states RxSight will present at the conference; no specific presentation topics were disclosed.

Will RxSight (RXST) release earnings or guidance during the JP Morgan presentation?

The announcement did not include any earnings, guidance, or financial data.

Where is RxSight headquartered and what does the company do?

RxSight is an ophthalmic medical device company focused on customized vision for patients after cataract surgery.